On February 19th Eisai was pleased to join other global leaders from the field of research and development for a discussion about the UK life sciences landscape.
This inaugural meeting was hosted by Professor Sir John Bell and Lord James Bethell, Minister for Innovation, and was convened via a collaboration between the Office for Life Sciences, the Department for International Trade and the Japanese Pharmaceutical Group.
The objective was to showcase scientific and research excellence in the UK and address global concerns that have resulted from the UK’s departure from the European Union. Speakers included:
• Sir Paul Nurse, Chief Executive and Director of the Francis Crick Institute presented the latest research taking place there, with a focus on cell & gene therapy
• Dr Andy Roddam, CEO of Our Future Health addressed the huge potential to make the UK the home of data-driven life sciences research, innovation and development
• Professor Martin Landray, Professor of Medicine and Epidemiology at Oxford University presented the opportunities for innovative population health trials
• Dr June Raine, Chief Executive of the MHRA set out her vision for the regulator as it enters a new era following the UK’s departure from the European Union
Eisai is looking forward to participating in an ongoing dialogue of this nature and to the implementation of the recommendations that were put forward at the meeting.